Meridian Medical Group

Meridian Medical Technologies is a specialized pharmaceutical and medical device company that focuses on the development and manufacturing of emergency auto-injectors and medical countermeasures. The company is best known as the long-term manufacturer of the EpiPen (epinephrine auto-injector) for Viatris (formerly Mylan). In addition to its commercial products, Meridian is a critical supplier to the U.S. Department of Defense and other global government agencies, providing specialized auto-injectors for nerve agent antidotes and chemical defense. Formerly a subsidiary of Pfizer, the company was acquired by Altaris Capital Partners in 2021. Meridian's core competency lies in the integration of complex drug formulations with sophisticated delivery systems, serving both the emergency medicine and defense sectors.